Can antioxidants be beneficial in the treatment of lead poisoning?

Free Radical Biology and Medicine

Volumn 29, Issue 10, 2000, Pages 927-945

  Gurer, Hande ^a   Ercal, Nuran ^b  

^a HACETTEPE UNIVERSITY   (Turkey)

^b MISSOURI UNIVERSITY OF SCIENCE AND TECHNOLOGY   (United States)

Author keywords

Antioxidants; Free radicals; Lead poisoning; Oxidative stress; Treatment

Indexed keywords

ACETYLCYSTEINE; ALPHA TOCOPHEROL; AMINOLEVULINIC ACID; ANTIOXIDANT; ASCORBIC ACID; CAPTOPRIL; CHELATING AGENT; DIMERCAPROL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; EDETATE CALCIUM DISODIUM; ETHOXYQUIN; FREE RADICAL; GLUTATHIONE; HEMOGLOBIN; LEAD; METHIONINE; OXIDIZING AGENT; PENICILLAMINE; PYRIDOXINE; REACTIVE OXYGEN METABOLITE; S ADENOSYLMETHIONINE; SELENIUM; SUCCIMER; TAURINE; THIAMINE; THIOCTIC ACID; THIOL DERIVATIVE; ZINC;

ANTIOXIDANT ACTIVITY; CELL METABOLISM; CHELATION THERAPY; DRUG INDUCED DISEASE; DRUG MECHANISM; DRUG STRUCTURE; HUMAN; LEAD BLOOD LEVEL; LEAD POISONING; MEMBRANE DAMAGE; MEMBRANE STRUCTURE; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BINDING; REVIEW;

AMINOLEVULINIC ACID; ANIMALS; ANTIOXIDANTS; CELL MEMBRANE; CHELATING AGENTS; HEMOGLOBINS; HUMANS; LEAD; LEAD POISONING; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES;

EID: 0034669377     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5849(00)00413-5     Document Type: Review

References (164)

1. Mechanisms of lipid peroxide formation in tissues. Role of metals and haematin proteins in the catalysis of the oxidation of unsaturated fatty acids
2. Lead-catalyzed peroxidation of essential unsaturated fatty acid
3. Brain biochemistry of infants and rats exposed to lead
4. Lead-induced regional lipid peroxidation in brain
5. Evaluation of malondialdehyde as an index of lead damage in rat brain homogenates
6. Effect of lead on lipid peroxidation in liver of rats
7. Lead-induced lipid peroxidation and antioxidant defense components of developing chick embryos
8. Lead intoxication: Antioxidant defenses and oxidative damage in rat brain
9. Is lead toxicosis a reflection of altered fatty acid composition of membranes?
10. Determination of lead in plasma and studies on its relationship to lead in erythrocytes
11. An age-specific kinetic model of lead metabolism in humans
12. Iron-mediated oxidative stress and erythrocytes
13. The anemia of lead poisoning: A review
14. Filterability of erythrocytes from vitamin E-deficient lead-poisoned rats
15. Nonrandom shortening of red cell survival times in men exposed to lead
16. Studies on sodium-potassium activated ATPase. V. Correlation of enzyme activity with cation flux in six tissues
17. +)-ATPase in lead poisoning
18. +)-ATPase
19. Effect of lead on erythrocyte membranes
20. Dietary modification of lead toxicity: Effects on fatty acid and eicosanoid metabolism in chicks
21. Lead-induced tissue fatty acid alterations and lipid peroxidation
22. Thermoconductometric investigation of phosphatidylcholine in aqueous tertiary butanol solutions in the absence and presence of metal ions
23. Impacted lead on phospholipid metabolism in human erythrocyte membranes
24. Relationship between the hemolytic action of heavy metals and lipid peroxidation
25. Copper-induced generation of superoxide in human red cell membrane
26. The effect of lead on hemoglobin-catalyzed lipid peroxidation
27. Lead-hemoglobin interaction as a possible source of reactive oxygen species - A chemiluminescent study
28. Activated oxygen and haemolysis
29. Biomonitoring lead exposure with ALAD activity ratios
30. Health effects of lead: II
31. Free radical generation during δ-aminolevulinic acid autoxidation: Induction by hemoglobin and connections with porphyrinpathies
32. Free radicals involvement in neurological porphyrias and lead poisoning
33. Damage to rat liver mitochondria promoted by δ-aminolevulinic acid-generated reactive oxygen species: Connections with acute intermittent porphria and lead poisoning
34. + and 5-aminolevulinic acid-derived oxyradicals promote injury to isolated mitochondria?
35. Oxidative stress in acute intermittent porphyria and lead poisoning may be triggered by 5-aminolevulinic acid
36. Generation of active oxygen species during coupled autoxidation of oxyhemoglobin and δ-aminolevulinic acid
37. DNA alkylation by 4,5-dioxovaleric acid, the final oxidation product of 5-aminolevulinic acid
38. Hydroxyl radicals are involved in the oxidation of isolated and cellular DNA bases by 5-aminolevulinic acid
39. Changes in organ nonprotein sulfhydryl and glutathione concentrations during acute and chronic administration of inorganic lead to chicks
40. Lead toxicity related to glutathione metabolism
41. Oxygen toxicity related to exposure to lead
42. Serum lipid peroxide level and blood superoxide dismutase activity in workers with occupational exposure to lead
43. Lipid peroxidation and concentration of glutathione in erythrocytes from workers exposed to lead
44. Indices of lead-exposure in blood and urine of lead-exposed workers and concentrations of major and trace elements and activities of SOD, GSH-Px and catalase in their blood
45. Effects of exposure to lead on selected biochemical and hematological variables
46. Biochemical effects of mercury, cadmium and lead
47. Metal-induced alterations of δ-aminolevulinic acid dehydratase
48. Effect of lead on δ-aminolevulinic acid dehydrase activity in red blood cells
49. Structure of human glucose-6-phosphate dehydrogenase
50. Inhibition of the pentose phosphate shunt by lead: A potential mechanism for hemolysis in lead poisoning
51. The influence of pH and methylene blue on the pathways of glucose utilization and lactate formation in erythrocytes of man
52. Antioxidant effects of N-acetylcysteine and succimer in red blood cells from lead-exposed rats
53. The effect of lead on oxidative hemolysis and erythrocyte defense mechanisms in the rat
54. Effects of short-term occupational exposure to lead on erythrocyte glucose-6-phosphate dehyrogenase activity and serum cholesterol
55. Human erythrocyte glutathione reductase and glucose 6-phosphate dehydrogenase activities in normal subjects and in persons exposed to lead
56. Behavior of erythrocyte glucose-6-phosphate dehydrogenase in rats treated subcutaneously with lead acetate
57. Mechanisms of the toxic effect of lead. I. Free lead in erythrocyte
58. Erythrocyte enzymes in experimental lead poisoning
59. Glutathione as an antioxidant: Toxicological aspects
60. Glutathione
61. In vitro assessment of the toxicity of metal compounds. IV. Disposition of metals in cells: Interaction with membranes, glutathione, metallothionein, and DNA
62. Nuclear magnetic resonance studies of the solution chemistry of metal complexes. IX. The binding of cadmium, zinc, lead and mercury by glutathione
63. Effect of diet on the response in rats to lead acetate given orally or in the drinking water
64. Evolution of glutathione metabolism
65. Lipoperoxidative damage on lead exposure in rat brain and its implications on membrane bound enzymes
66. Effects of selenium antagonists on cancer susceptibility: New aspects of chronic heavy metal toxicity
67. Role of selenium against lead toxicity in male rats
68. Selenium in the treatment of heavy metals poisoning and chemical carcinogenesis
69. Studies on the biosynthesis of blood pigment. Haem synthesis in hemolysed erythrocytes of chicken blood
70. Erythrocyte superoxide dismutase activity and other parameters of copper status in rats ingesting lead acetate
71. Effects of dietary copper supplementation on erythrocyte superoxide dismutase activity, ceruloplasmin and related parameters in rats ingesting lead acetate
72. Effect of lead on oxygen free radical metabolism: Inhibition of superoxide dismutase activity
73. 2, superoxide dismutase, and xanthine oxidase
74. Treatment guidelines for lead exposure in children
75. The use of chelating agents in occupational lead poisoning
76. Chelation therapy for childhood lead poisoning
77. Hemolysis during BAL chelation therapy for high blood lead levels in two glucose-6-phosphate dehydrogenase deficient children
78. Management of childhood lead poisoning
79. Mobilization of heavy metals by newer, therapeutically useful chelating agents
80. Lead poisoning
81. Heavy metals and heavy metal antagonists
82. 14-labeled ethylenediaminetetra acetic acid in human beings
83. Mobilization and redistribution of lead over the course of calcium disodium ethylenediamine tetraacetate chelation therapy
84. New developments in pediatric lead poisoning
85. Evaluation of the potential role of chelation therapy in treatment of low to moderate lead exposure
86. EDTA plus zinc as therapy of lead intoxication: Preliminary results
87. Reversible nephrotoxic reactions to a combined 2,3-dimercapto-1-propanol and calcium disodium ethylenediaminetetra acetic acid regimen in asymptomatic children with elevated blood lead levels
88. Penicillamine, a new oral therapy for Wilson's disease
89. Oral chelators for childhood lead poisoning
90. The use of chelating agents in the treatment of acute and chronic lead intoxication in childhood
91. Ambulatory treatment of lead poisoning: Report of 1155 cases
92. Oral penicillamine therapy for chronic lead poisoning in children
93. Efficacy and toxicity of D-penicillamine in low-level lead poisoning
94. Chelation therapy in children with subclinical plumbism
95. Experience with D-penicillamine in treating lead poisoning
96. Reduction in oral penicillamine absorbtion by food, antacid, and ferrous sulfate
97. Pharmacokinetics of oral 500 mg penicillamine: Effects of antacids on absorbtion
98. Determination and metabolism of dithiol chelating agents. X. In humans, meso-2,3-dimercaptosuccinic acid is bound to plasma proteins via mixed disulfide formation
99. Succimer: The first approved oral lead chelator
100. Mobilization of lead over the course of DMSA chelation therapy and long term efficacy
101. Controlled study of meso-2,3-dimercaptosuccinic acid for the management of childhood lead intoxication
102. Succimer, an oral chelator
103. Influence of vitamin B6 status on aspects of lead poisoning in rats
104. Thiamine and zinc in prevention or therapy of lead intoxication
105. Interaction of zinc, methionine or their combination with lead at gastrointestinal or post-absorptive level in rats
106. Influence of thiamine and ascorbic acid supplementation on the antidotal efficacy of thiol chelators in experimental lead intoxication
107. Preventive and therapeutic role of vitamin E in chronic plumbism
108. Influence of pyridoxine on lead intoxication in rats
109. Beneficial effects of zinc supplementation during chelation treatment of lead intoxication in rats
110. The physiological role of zinc as an antioxidant
111. Relationship of ascorbic acid to blood lead levels
112. Interaction of dietary lead with fish oil and antioxidant in chicks
113. Diabetes-induced metabolic abnormalities in myocardium: Effect of antioxidant therapy
114. Fumonisin B1-induced DNA damage in rat liver and spleen: Effects of pretreatment with coenzyme Q10, L-carnitine, alpha-tocopherol and selenium
115. Ethanol potentiates lead-induced inhibition of rat brain antioxidant defense systems
116. Beneficial effects of S-Adenosyl-L-Methionine on aminolevulinic acid deydratase, glutathione and lipid peroxidation during acute lead-ethanol administration in mice
117. In vivo indices of oxidative stress in lead-exposed C57BL/6 mice are reduced by treatment with meso-2,3-dimercaptosuccinic acid or N-acetylcysteine
118. N-acetylcysteine
119. Treatment of paracetamol poisoning with N-acetylcysteine
120. Acetylcysteine: A drug with an interesting past and a fascinating future
121. Lung protection by a thiol-containing antioxidant: N-acetylcysteine
122. The antioxidant action of N-acetylcysteine: Its reaction with hydrogen peroxide, hydroxyl radical, superoxide, and hypochlorous acid
123. Clinical pharmacokinetics of N-acetylcysteine
124. Experimental chelation therapy in chromium, lead, and boron intoxication with N-acetylcysteine and other compounds
125. Comparison of the effectiveness of several chelators after single administration on the toxicity, excretion and distribution of cobalt
126. Differential effect of N-acetylcysteine on excretion of the metals Hg, Cd, Pb, and Au
127. Does N-acetylcysteine increase the excretion of trace metals (calcium, magnesium, iron, zinc and copper) when given orally?
128. Effects of N-acetylcysteine and 2,3-dimercaptosuccinic acid on lead induced oxidative stress in rat lenses
129. Pro-oxidant effects of δ-aminolevulinic acid on Chinese hamster ovary cells
130. Antioxidant role of alpha-lipoic acid in lead toxicity
131. Biosynthesis of lipoic via unsaturated fatty acids
132. Multienzyme complexes
133. Alpha-lipoic acid as a biological antioxidant
134. The pharmacology of the antioxidant lipoic acid
135. α-Lipoic acid increases intracellular glutathione in a human T-lymphocyte jurkat cell line
136. α-Lipoic acid protects against reperfusion injury following cerebral ischemia in rats
137. Effects of some sulfur-containing antioxidants on lead-exposed lenses
138. Does captopril attenuate reperfusion-induced myocardial dysfunction by scavenging free radicals?
139. Direct scavenging of free radicals by captopril, an angiotensin converting enzyme inhibitor
140. Captopril scavenges hydrogen peroxide and reduces, but does not eliminate, oxidant-induced cell injury
141. Protective behavior of captopril on Hg++-induced toxicity on kidney mitochondria. In vivo and in vitro experiments
142. Captopril as an antioxidant in lead-exposed Fisher 344 rats
143. Cardiotoxicity and hypertension in rats after oral lead exposure
144. The effect of blood lead on blood pressure in children
145. Lead-induced hypertension: Interplay of nitric oxide and reactive oxygen species
146. Lead-induced hypertension. II. Response to sequential infusions of L-arginine, superoxide dismutase, and nitroprusside
147. Nitric oxide synthase expression in the course of lead-induced hypertension
148. Increased nitric oxide inactivation by reactive oxygen species in lead-induced hypertension
149. Lead promotes hydroxyl radical generation and lipid peroxidation in cultured aortic endothelial cells
150. Taurine: Biological update
151. Physiological actions of taurine
152. Taurine scavenges oxidized chlorine in biological systems
153. Taurine and ellagic acid: Two differently-acting natural antioxidants
154. Taurine attenuates nitric oxide- and reactive oxygen intermediate-dependent hepatocyte injury
155. The in vivo and in vitro protective properties of taurine
156. The antioxidant action of taurine, hypotaurine and their metabolic precursors
157. Management of childhood lead poisoning: A survey
158. Lead and IQ scores: A reanalysis
159. Low level lead exposure and the IQ of children: A meta-analysis of modern studies